Fagron’s $17 Million Acquisition of 100% Stake in Central de Drogas


Ritch, Mueller, Heather y Nicolau and Tellaeche y Vázquez Arana advised on the deal

Fagron executed its $17 Million acquisition of 100% Stake in Central de Drogas.

Fagron N.V. supplies pharmaceutical raw materials, equipment and supplies, oncepts and pharmaceutical compounding to pharmacies and hospital pharmacies. The Company, led by Rafael Padilla, Karin De Jong and Constantijn Van Rietschoten also develops new formulations for specific patients and patient groups.

Central de Drogas S.A. de C.V. wholesales prescription drugs, proprietary drugs, and toiletries. The Company distributes pharmaceutical, botanical, industrial, and food chemical raw material in Mexico

Ritch, Mueller, Heather y Nicolau advised Fagron with Luis Nicolau Gutiérrez (Picture), Gabriel Torres Escoto and Rodrigo Carreras Valle.

Tellaeche y Vázquez Arana advised Central de Drogas (Cedrosa) with Rafael Tellaeche, Nelsy Ancona and Agustina Farías

Involved fees earner: Rodrigo Carreras Valle – Ritch, Mueller, Heather y Nicolau, SC; Luis Nicolau Gutiérrez – Ritch, Mueller, Heather y Nicolau, SC; Gabriel Torres Escoto – Ritch, Mueller, Heather y Nicolau, SC; Nelsy Ancona – Tellaeche y Vázquez Arana; Rafael Tellaeche – Tellaeche y Vázquez Arana;

Law Firms: Ritch, Mueller, Heather y Nicolau, SC; Tellaeche y Vázquez Arana;

Clients: Central de Drogas SA de CV; Fagron Group BV;